» NeuroPhage to Participate on Neuroscience Drug Development Panel at MassBio Annual Meeting March 27, 2015

CAMBRIDGE, Mass., March 20, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Jonathan Solomon, CEO, will participate on an expert panel, "Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead," at the Massachusetts...

» New Analysis Looks at "Addiction Treatment Today And Tomorrow" and Policy Implications

WASHINGTON, March 17, 2015 /PRNewswire-USNewswire/ -- "Each year substance use disorders have a tangible impact on the societal and economic well-being of the United States," notes a new report from Dobson DaVanzo & Associates, LLC (Dobson | DaVanzo), developed for the National...

» CAMP LIVING WONDERS: Overnight Camp for Jewish Children with Developmental Disabilities Now Accepting Applications for Summer 2015 Campers and Staff

ATLANTA, March 18, 2015 /PRNewswire/ -- Summer camp – and all the excitement of swimming, campfires and color war -- is a happy rite of passage for many children. But for those with developmental disabilities such as ADHD, Asperger's Syndrome, Fragile X, Down's Syndrome,...